4686 J . Org. Chem., Vol. 66, No. 13, 2001
J aber et al.
1
with hexanes (20 mL), washed with brine (20 mL), dried over
anhydrous MgSO4, filtered and concentrated in vacuo. The
resulting orange oil was purified by flash chromatography on
silica gel (5-10% EtOAc/hexanes) to afford 46 mg (84%) of
THP 40 as a clear oil: IR (neat) 1741 cm-1; 1H NMR (500 MHz,
CDCl3) δ 4.90 (tt, J ) 11.3, 4.7 Hz, 1 H), 3.55-3.44 (m, 2 H),
2.47 (ddq, J ) 16.4 5.2, 2.6 Hz, 1 H), 2.27 (ddq, J ) 15.5, 7.7,
2.5 Hz, 1 H), 2.18 (ddd, J ) 12.2, 4.4, 4.3 Hz, 1 H), 2.04 (s, 3
H), 1.95 (dt, J ) 12.3, 4.3 Hz, 1 H), 1.78 (t, J ) 2.6 Hz, 3 H),
1.27 (q, J ) 11.3 Hz, 2 H), 1.21 (d, J ) 6.2 Hz, 3 H); 13C NMR
(500 MHz, CDCl3) δ 170.5, 77.7, 74.8, 74.1, 71.6, 70.3, 38.8,
36.2, 26.1, 21.6, 21.3, 3.5 Hz; Anal. Calcd for C12H18O3: C,
68.55; H, 8.63. Found: C, 68.80; H, 8.50.
cm-1; H NMR (500 MHz, CDCl3) δ 5.84 (ddd, J ) 17.2, 10.6,
5.7 Hz, 1 H), 5.25 (dd, J ) 17.2, 1.4 Hz, 1 H), 5.11 (dd, J )
10.6, 1.3 Hz, 1 H), 4.91 (tt, J ) 11.3, 4.9 Hz, 1 H), 3.89 (dddd,
J ) 7.5, 5.7, 3.4, 1.8 Hz, 1 H), 3.56 (dq, J ) 1.9, 6.2 Hz, 1 H),
2.03 (s, 3 H), 2.02-1.94 (m, 2 H), 1.33 (q, J ) 11.5 Hz, 1 H),
1.30-1.25 (m, 1 H), 1.24 (d, J ) 6.2 Hz, 2 H); 13C NMR (125
MHz, CDCl3) δ 170.5, 137.9, 115.6, 75.9, 71.5, 70.2, 38.7, 36.7,
21.6, 21.2 Hz; HRMS (EI/GC-MS) m/z calcd for C10H16O3 (M
- C2H3O2)+ 125.0922, found 125.0924. Anal. Calcd for
C
10H16O3: C, 65.19; H, 8.75. Found: C, 65.24; H, 8.94.
4-Br om o-2-m eth yl-6-pr open yltetr ah ydr opyr an (51). The
procedure described for the preparation of 12 was followed,
using R-acetoxy ether 47 (73 mg) to produce 65 mg (81%) of
THP 51 as a clear oil: IR (near) 2972, 1446, 965 cm-1; 1H NMR
(500 MHz, CDCl3) δ 5.68 (dq, J ) 15.4, 6.4 Hz, 1 H), 5.44 (dd,
J ) 15.4, 6.6 Hz, 1 H), 4.12 (tt, J ) 12.0, 4.3 Hz, 1 H), 3.76-
3.73 (m, 1 H), 3.45 (dq, J ) 12.2, 6.2 Hz, 1 H), 2.19 (dt, J )
4.0, 2.0 Hz, 2 H), 1.75 (q, J ) 11.6 Hz, 1 H), 1.69-1.62 (m, 4
H), 1.98 (d, J ) 6.2 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ
130.6, 128.2, 78.0, 73.7, 46.3, 44.5, 42.9, 21.5, 17.7 Hz; HRMS
(EI/GC-MS) m/z calcd for C9H15BrO (M)+ 218.0306, found
218.0304. Anal. Calcd for C9H20BrO; C, 49.33; H, 6.90.
Found: C, 49.50; H, 6.87.
Tetr a h yd r op yr a n s 41 a n d 42. The procedure described
for the preparation of 40 was followed, using R-acetoxy ether
35 (20 mg) to produce 17 mg (85%) of a clear oil. The product
was a 5:1 mixture of the regioisomers of 41 (major) and 42
(minor) by NMR analysis. Data for 41: IR (neat) 1741 cm-1
;
1H NMR (500 MHz, CDCl3) δ 5.80 (ddt, J ) 17.3, 10.1, 7.1 Hz,
0.2 H), 5.57-5.50 (m, 1 H), 5.41-5.37 (m, 1 H), 5.08-5.02 (m,
0.4 H), 4.93 (ddd, J ) 9.5, 4.7, 4.7 Hz, 0.2 H), 4.85 (tt, J )
16.1, 4.8 Hz, 1 H), 3.58-3.34 (m, 2.4 H), 2.37-2.17 (m, 2.4 H),
2.05 (s, 0.6 H), 2.03 (s, 3 H), 1.98-1.92 (m, 2 H), 1.60 (m, 0.4
H), 1.58 (dd, J ) 6.8, 0.8 Hz, 3 H), 1.42 (q J ) 12.4 Hz, 2 H),
1.21 (q, J ) 12.4 Hz, 2 H, d, J ) 6.5 Hz, 3 H), 1.13 (d, J ) 6.5
Hz, 0.6 H), 0.87 (d, J ) 7.0 Hz, 0.6 H); 13C NMR (125 MHz,
CDCl3) δ (major) 170.6, 126.2, 125.6, 75.2, 71.5, 70.6, 39.0, 36.5,
33.5, 21.7, 21.3, 13.0; (minor) 170.6, 134.3, 117.1, 75.3, 74.1,
73.7, 36.5, 31.6, 30.8, 18.4, 14.1, 5.4; LRMS (CI) m/z calcd for
2-Meth yl-6-pr open yltetr ah ydr opyr an -4-yl Acetate (52).
The procedure described for the preparation of 13 was followed,
using R-acetoxy ether 47 (308 mg) to produce 274 mg (89%) of
52 as an oil: IR (neat) 2973, 1742, 967 cm-1; H NMR (500
1
MHz, CDCl3) δ 5.70 (ddq, J ) 15.4, 1.0, 6.5 Hz, 1 H), 5.48 (ddd,
J ) 15.4, 3.3, 1.6 Hz, 1 H), 4.88 (tt, J ) 9.5, 4.7 Hz, 1 H), 3.82
(ddd, J ) 10.5, 6.7, 1.0 Hz, 1 H), 3.52 (ddt, J ) 11.3, 2.0, 6.2
Hz, 1 H), 2.02 (s, 3 H), 2.06-1.91 (m, 2 H), 1.66 (ddd, J ) 6.5,
1.6, 0.74 Hz, 3 H), 1.34 (q, J ) 11.4 Hz, 1 H), 1.26-1.16 (m, 4
H); 13C NMR (125 MHz, CDCl3) δ 170.5, 131.0, 128.0, 76.0,
71.2, 70.3, 38.7, 37.0, 21.7, 21.3, 122.8 Hz; HRMS (CI/
isobutane) m/z calcd for C11H18O3 (M + H)+ 199.1334, found
199.1340. Anal. Calcd for C11H18O3: C, 66.64; H, 9.15. Found:
C, 66.47; H, 9.41.
Tetr a h yd r op yr a n 53. The procedure described for the
preparation of 12 was followed, using R-acetoxy ether 48 (213
mg) to produce 131 mg (57%) of 53 as a colorless oil: IR (neat)
3081, 3026, 747, 693 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.40-
7.24 (m, 5 H), 6.63 (d, J ) 16.0 Hz, 1 H), 6.20 (ddd, J ) 16.0,
6.2, 1.5 Hz, 1 H), 4.24 (tt, J ) 12.0, 4.5 Hz, 1 H), 4.04 (ddd, J
) 9.2, 6.2, 1.2 Hz, 1 H), 3.59 (ddq, J ) 11.0, 1.8, 6.2 Hz, 1 H),
2.38 (ddd, J ) 11.0, 4.3, 2.0 Hz, 1 H), 2.29 (ddd, J ) 11.0, 4.3,
2.0 Hz, 1 H), 1.93 (q, J ) 12.7 Hz, 1 H), 1.78 (q, J ) 12.5 Hz,
1 H), 1.30 (d, J ) 6.2 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ
136.4, 131.2, 128.6, 128.5, 127.8, 126.5, 76.7, 73.6, 46.1, 44.6,
43.0, 21.5 Hz; HRMS (CI/isobutane) m/z calcd for C14H17BrO
(M)+ 280.0462, found 280.0463.
C
12H20O3 (M + H)+ 213, found 213; HRMS (EI/GC-MS) m/z
calcd for C12H20O3 (M - C4H8)+ 156.0785, found 156.0790.
Tetr a h yd r op yr a n 43. The procedure described for the
preparation of 40 was followed, using R-acetoxy ether 36 (50
mg) to produce 43 mg (87%) of 43 as a clear oil: IR (neat) 1741
cm-1; H NMR (500 MHz, CDCl3) δ 5.50-5.26 (m, 2 H), 4.85
1
(tt, J ) 16.1, 4.8 Hz, 1 H), 3.51-3.45 (m, 1 H), 3.36-3.31 (m,
1 H), 2.32-2.27 (m, 1 H), 2.1 (q, J ) 7.2 Hz, 1 H), 2.0 (s, 3 H),
1.97-1.91 (m, 2 H), 1.63 (dd, J ) 6.0, 1.0 Hz, 3 H), 1.25-1.16
(m, 2 H, d, J ) 6.2 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ
170.6, 127.7, 126.6, 75.3, 71.5, 70.6, 39.3, 38.9, 36.4, 21.7, 21.3,
18.0; LRMS (CI/NH4) m/z for C12H20O3 (M + H)+ 213, found
213; HRMS (EI/GC-MS) m/z for C12H20O3 (M - C4H8)+
156.0785, found 156.0781.
Tetr a h yd r op yr a n s 44 a n d 45. The procedure described
for the preparation of 40 was followed, using R-acetoxy ether
39 (16 mg) to produce 12.5 mg (76%) of a clear oil. The product
was a 2:1 mixture of regioisomers of 45 (major) and 44 (minor)
1
by NMR analysis: IR (neat) 1741 cm-1; H NMR (500 MHz,
CDCl3) δ 5.62-5.43 (m, 3 H), 5.0 (dt, J ) 12.0, 4.8 Hz, 1 H),
4.63 (td, J ) 10.8, 4.7 Hz, 0.5 H), 3.65-3.61 (m, 1 H), 3.49-
3.41 (m, 1.5 H), 3.25-3.19 (m, 0.5 H), 2.38-2.10 (m, 1.5 H),
2.06 (s, 4.5 H), 1.98 (m, 1 H), 1.74-1.65 (m, 3 H), 1.61 (d, J )
6.8 Hz, 1.5 H), 1.53-1.40 (m, 1.5 H), 1.35-1.30 (m, 0.5 H) 1.28
(d, J ) 6.0 Hz, 1.5 H), 1.20 (d, J ) 6.5 Hz, 3 H), 0.93 (d, J )
6.9 Hz, 3 H), 0.90 (d, J ) 6.6 Hz, 1.5 H); 13C NMR (100 MHz,
CDCl3) δ (major) 170.1, 127.5, 126.4, 75.8, 74.0, 73.8, 39.3, 36.6,
31.0, 21.5, 18.7, 18.2, 5.6; (minor) 170.1, 125.9, 125.4, 79.2,
75.6, 74.9, 42.6, 37.2, 33.6, 21.4, 18.2, 13.4, 13.2; HRMS (EI/
GC-MS) m/z calcd for C13H22O3 (M)+ 226.1569, found 226.1567.
4-Br om o-2-m eth yl-6-vin yltetr a h yd r op yr a n (49). The
procedure described for the preparation of 12 was followed,
using R-acetoxy ether 46 (108 mg) to produce 73 mg (61%) of
Tetr a h yd r op yr a n 54. The procedure described for the
preparation of 13 was followed, using R-acetoxy ether 48 (107
mg) to produce 86 mg (80%) of THP 54 as a colorless oil: IR
(neat) 3059, 3027, 1740 cm-1; H NMR (500 MHz, CDCl3) δ
1
7.39-7.20 (m, 5 H), 6.60 (d, J ) 16.0 Hz, 1 H), 6.21 (dd, J )
16.0, 6.1 Hz, 1 H), 4.96 (tt, J ) 11.3, 4.7 Hz, 1 H), 4.12-4.06
(m, 1 H), 3.63 (ddq, J ) 12.4, 1.9, 6.2 Hz, 1 H), 2.13-2.06 (m,
1 H), 2.05 (s, 3 H), 2.04-1.98 (m, 1 H) 1.45 (t, J ) 11.5 Hz, 1
H), 1.33 (t, J ) 11.3 Hz, 1 H), 1.28 (d, J ) 6.2 Hz, 3 H); 13C
NMR (125 MHz, CDCl3) δ 170.5, 136.5, 130.8, 129.1, 128.4,
127.6, 126.5, 75.8, 71.6, 70.2, 38.2, 37.1, 21.7, 21.3 Hz. Anal.
Calcd for C16H20O3: C, 73.82; H, 7.74. Found: C, 73.70; H,
7.62.
1
49 as a light yellow oil: IR (neat) 3027, 3058 cm-1; H NMR
(500 MHz, CDCl3) δ 5.84 (ddd, J ) 17.2, 10.6, 5.7 Hz, 1 H),
5.26 (dd, J ) 17.2, 1.4 Hz, 1 H), 5.11 (dd, J ) 10.6, 1.3 Hz, 1
H), 4.17 (tt, J ) 12.0, 4.3 Hz, 1 H), 3.85-3.82 (m, 1 H), 3.51
(dq, J ) 1.9, 6.2 Hz, 1 H), 2.29-2.06 (m, 2 H), 1.78 (q, J )
12.3 Hz, 1 H), 1.72 (q, J ) 12.3 Hz, 1 H), 1.23 (d, J ) 6.2 Hz,
3 H); 13C (125 MHz, CDCl3) δ 137.5, 115.9, 78.0, 73.5, 46.3,
Ack n ow led gm en t. Support has been provided by
the National Institutes of Health (CA 81635) and the
University of California, Irvine, UROP program.
Su p p or tin g In for m a tion Ava ila ble: Experimental pro-
cedures for cyclization precursors 8, 9, 11, 32, 33, and 38. This
material is available free of charge via the Internet at
http://pubs.acs.org.
44.6, 42.6, 21.5 Hz; HRMS (CI/isobutane) m/z calcd for C8H13
-
BrO (M - Br)+ 125.0966, found 125.0969.
2-Meth yl-6-vin yltetr ah ydr opyr an -4-yl Acetate (50). The
procedure described for the preparation of 13 was followed,
using R-acetoxy ether 46 (108 mg) to produce 59 mg (55%) of
50 as a single diastereomer: IR (neat) 3010, 1740, 1380, 962
J O010232W